Last 12 months
Inside the activity.
9 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 1 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 5 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2021 Filed Mar 18, 2021 01:56 UTC |
MIRZAYANTZ NICOLASGroup President Fragrance
|
Tax withholdingCommon Stock | 133 | $136.79 | $18,193.07 |
DisclosureSEC source: 0001225208-21-005551 · doc4.xml · nonDerivative · entry 2 MIRZAYANTZ NICOLAS · CIK 0001211907 · Group President Fragrance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,763.723 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 01:56 UTC |
MIRZAYANTZ NICOLASGroup President Fragrance
|
GrantCommon Stock | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-005551 · doc4.xml · nonDerivative · entry 1 MIRZAYANTZ NICOLAS · CIK 0001211907 · Group President Fragrance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,896.723 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2018-2020 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 2, 2018, the first stock trading day of the LTIP cycle. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 01:56 UTC |
Fortanet FranciscoEVP, Operations
|
Tax withholdingCommon Stock | 74 | $136.79 | $10,122.46 |
DisclosureSEC source: 0001225208-21-005550 · doc4.xml · nonDerivative · entry 2 Fortanet Francisco · CIK 0001351377 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,496.438 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 01:56 UTC |
Fortanet FranciscoEVP, Operations
|
GrantCommon Stock | 193 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-005550 · doc4.xml · nonDerivative · entry 1 Fortanet Francisco · CIK 0001351377 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,570.438 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2018-2020 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 2, 2018, the first stock trading day of the LTIP cycle. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 01:55 UTC |
Anderson Robert G.Controller
|
GrantStock Equivalent Unit · Derivative | 9.995 | $136.79 | $1,367.22 |
DisclosureSEC source: 0001225208-21-005548 · doc4.xml · derivative · entry 4 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,491.782 Underlying: Common Stock · 9.995 shares Expires not disclosed F6 · derivative.exercise_price: The Stock Units ("Units") convert to Common Stock on a one-for-one basis. F7 · shares: Reflects Units under the Company's deferred compensation plan resulting from deferral of compensation and the 25% premium contributed by the Company on such Units. Units contributed by the Company are subject to vesting based on continued employment through December 31, 2022. F5 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F5 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 01:55 UTC |
Anderson Robert G.Controller
|
GrantStock Equivalent Unit · Derivative | 128.27 | $136.79 | $17,546.05 |
DisclosureSEC source: 0001225208-21-005548 · doc4.xml · derivative · entry 3 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,481.787 Underlying: Common Stock · 128.27 shares Expires not disclosed F3 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F4 · shares: Reflects Units received upon deferral of a portion of the reporting person's annual incentive plan into the Company's stock fund and the premium contributed by the Company on such Units. The Company premium, or 25.654 of the acquired Units, are subject to vesting based on employment through December 31, 2022. F5 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F5 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 01:55 UTC |
Anderson Robert G.Controller
|
Tax withholdingCommon Stock | 40 | $136.79 | $5,471.60 |
DisclosureSEC source: 0001225208-21-005548 · doc4.xml · nonDerivative · entry 2 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,107.717 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 01:55 UTC |
Anderson Robert G.Controller
|
GrantCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-005548 · doc4.xml · nonDerivative · entry 1 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,147.717 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2018-2020 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 2, 2018, the first stock trading day of the LTIP cycle. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 01:55 UTC |
Fibig AndreasDirector · CEO
|
GrantStock Equivalent Unit · Derivative | 49.498 | $136.79 | $6,770.83 |
DisclosureSEC source: 0001225208-21-005549 · doc4.xml · derivative · entry 3 Fibig Andreas · CIK 0001514412 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,053.46 Underlying: Common Stock · 49.498 shares Expires not disclosed F1 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F4 · shares: Reflects Units under the Company's deferred compensation plan resulting from deferral of compensation and the 25% premium contributed by the Company on such Units. Units contributed by the Company are subject to vesting based on continued employment through December 31, 2022. F3 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F3 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 01:55 UTC |
Fibig AndreasDirector · CEO
|
GrantStock Equivalent Unit · Derivative | 1,944 | $136.79 | $265,919.76 |
DisclosureSEC source: 0001225208-21-005549 · doc4.xml · derivative · entry 2 Fibig Andreas · CIK 0001514412 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,003.962 Underlying: Common Stock · 1,944 shares Expires not disclosed F1 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F2 · shares: These Units represent the deferral of the 50% portion of the reporting person's payout under the 2018-2020 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 2, 2018, the first stock trading day of the LTIP cycle. F3 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F3 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 01:55 UTC |
Suarez Gonzalez SusanaEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 83 | $136.79 | $11,353.57 |
DisclosureSEC source: 0001225208-21-005547 · doc4.xml · nonDerivative · entry 2 Suarez Gonzalez Susana · CIK 0001691234 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,864 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 01:55 UTC |
Suarez Gonzalez SusanaEVP, Chief HR Officer
|
GrantCommon Stock | 181 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-005547 · doc4.xml · nonDerivative · entry 1 Suarez Gonzalez Susana · CIK 0001691234 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,947 F1 · shares: These shares represent the 50% portion of the reporting person's payout under the 2018-2020 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 2, 2018, the first stock trading day of the LTIP cycle. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 01:55 UTC |
Jilla RustomCFO
|
GrantStock Equivalent Unit · Derivative | 17.362 | $136.79 | $2,374.95 |
DisclosureSEC source: 0001225208-21-005546 · doc4.xml · derivative · entry 2 Jilla Rustom · CIK 0001648161 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434.4 Underlying: Common Stock · 17.362 shares Expires not disclosed F1 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F2 · shares: Reflects Units under the Company's deferred compensation plan resulting from deferral of compensation and the 25% premium contributed by the Company on such Units. Units contributed by the Company are subject to vesting based on continued employment through December 31, 2022. F3 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F3 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:09 UTC |
Schultz KareDirector
|
GrantRestricted Stock Units · Derivative | 255 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-004532 · doc4.xml · derivative · entry 1 Schultz Kare · CIK 0001724567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255 Underlying: Common Stock · 255 shares Expires 2021-05-06 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:08 UTC |
Heinzel MatthiasDirector
|
GrantRestricted Stock Units · Derivative | 255 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-004531 · doc4.xml · derivative · entry 1 Heinzel Matthias · CIK 0001777444 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255 Underlying: Common Stock · 255 shares Expires 2021-05-06 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:08 UTC |
Boor Kathryn JeanDirector
|
GrantRestricted Stock Units · Derivative | 255 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-004530 · doc4.xml · derivative · entry 1 Boor Kathryn Jean · CIK 0001761826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255 Underlying: Common Stock · 255 shares Expires 2021-05-06 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:08 UTC |
GORDON ILENE SDirector
|
GrantRestricted Stock Units · Derivative | 255 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-004529 · doc4.xml · derivative · entry 1 GORDON ILENE S · CIK 0001049959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255 Underlying: Common Stock · 255 shares Expires 2021-05-06 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:08 UTC |
DAVIDSON CAROL ANTHONYDirector
|
GrantRestricted Stock Units · Derivative | 255 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-004528 · doc4.xml · derivative · entry 1 DAVIDSON CAROL ANTHONY · CIK 0001277489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255 Underlying: Common Stock · 255 shares Expires 2021-05-06 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:08 UTC |
BREEN EDWARD DDirector
|
GrantRestricted Stock Units · Derivative | 255 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-004527 · doc4.xml · derivative · entry 2 BREEN EDWARD D · CIK 0001223619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255 Underlying: Common Stock · 255 shares Expires 2021-05-06 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 22:12 UTC |
Jilla RustomCFO
|
GrantStock Equivalent Unit · Derivative | 17.526 | $135.51 | $2,374.95 |
DisclosureSEC source: 0001225208-21-004284 · doc4.xml · derivative · entry 2 Jilla Rustom · CIK 0001648161 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417.038 Underlying: Common Stock · 17.526 shares Expires not disclosed F1 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F2 · shares: Reflects Units under the Company's deferred compensation plan resulting from deferral of compensation and the 25% premium contributed by the Company on such Units. Units contributed by the Company are subject to vesting based on continued employment through December 31, 2022. F3 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F3 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 22:12 UTC |
Fibig AndreasDirector · CEO
|
GrantStock Equivalent Unit · Derivative | 49.966 | $135.51 | $6,770.89 |
DisclosureSEC source: 0001225208-21-004286 · doc4.xml · derivative · entry 2 Fibig Andreas · CIK 0001514412 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,059.962 Underlying: Common Stock · 49.966 shares Expires not disclosed F1 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F2 · shares: Reflects Units under the Company's deferred compensation plan resulting from deferral of compensation and the 25% premium contributed by the Company on such Units. Units contributed by the Company are subject to vesting based on continued employment through December 31, 2022. F3 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F3 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 22:11 UTC |
Anderson Robert G.Controller
|
GrantStock Equivalent Unit · Derivative | 10.089 | $135.51 | $1,367.16 |
DisclosureSEC source: 0001225208-21-004285 · doc4.xml · derivative · entry 2 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,353.517 Underlying: Common Stock · 10.089 shares Expires not disclosed F1 · derivative.exercise_price: The Stock Units ("Units") convert to Common Stock on a one-for-one basis. F2 · shares: Reflects Units under the Company's deferred compensation plan resulting from deferral of compensation and the 25% premium contributed by the Company on such Units. Units contributed by the Company are subject to vesting based on continued employment through December 31, 2022. F3 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F3 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 22:34 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionRestricted Stock Units · Derivative | 584 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003540 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,535 Underlying: Common Stock · 584 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 19, 2021. F4 · derivative.expiration_date: The RSUs vested on February 19, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 22:34 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Tax withholdingCommon Stock | 192 | $139.24 | $26,734.08 |
DisclosureSEC source: 0001225208-21-003540 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 691 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 22:34 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionCommon Stock | 584 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003540 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 22:34 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003539 · doc4.xml · derivative · entry 3 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,782 Underlying: Common Stock · 708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 19, 2021. F4 · derivative.expiration_date: The RSUs vested on February 19, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 22:34 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Tax withholdingCommon Stock | 277 | $139.24 | $38,569.48 |
DisclosureSEC source: 0001225208-21-003539 · doc4.xml · nonDerivative · entry 2 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 22:34 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionCommon Stock | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003539 · doc4.xml · nonDerivative · entry 1 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 22:34 UTC |
Herriott SimonPresident Health & Biosciences
|
Exercise / conversionRestricted Stock Units · Derivative | 616 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003538 · doc4.xml · derivative · entry 3 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,758 Underlying: Common Stock · 616 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 19, 2021. F4 · derivative.expiration_date: The RSUs vested on February 19, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 22:34 UTC |
Herriott SimonPresident Health & Biosciences
|
Tax withholdingCommon Stock | 190 | $139.24 | $26,455.60 |
DisclosureSEC source: 0001225208-21-003538 · doc4.xml · nonDerivative · entry 2 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 848 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 22:34 UTC |
Herriott SimonPresident Health & Biosciences
|
Exercise / conversionCommon Stock | 616 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003538 · doc4.xml · nonDerivative · entry 1 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 19, 2021 Filed Jun 2, 2021 20:46 UTC Amendment |
Herriott SimonPresident Health & Biosciences
|
Tax withholdingCommon Stock | 155 | $139.24 | $21,582.20 |
DisclosureSEC source: 0001225208-21-008816 · doc4a.xml · nonDerivative · entry 1 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,413 F1 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Number of shares withheld was misreported due to administrative error. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC |
Herriott SimonPresident Health & Biosciences
|
Exercise / conversionRestricted Stock Units · Derivative | 105 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002882 · doc4.xml · derivative · entry 6 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 105 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F4 · shares: Reflects vesting and settlement of RSUs granted on February 15, 2018. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC |
Herriott SimonPresident Health & Biosciences
|
Tax withholdingCommon Stock | 35 | $136.21 | $4,767.35 |
DisclosureSEC source: 0001225208-21-002882 · doc4.xml · nonDerivative · entry 4 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC |
Herriott SimonPresident Health & Biosciences
|
Exercise / conversionCommon Stock | 105 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002882 · doc4.xml · nonDerivative · entry 3 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Reflects vesting and settlement of RSUs granted on February 15, 2018. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionRestricted Stock Units · Derivative | 81 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002881 · doc4.xml · derivative · entry 6 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 81 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F4 · shares: Reflects vesting and settlement of RSUs granted on February 15, 2018. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Tax withholdingCommon Stock | 27 | $136.21 | $3,677.67 |
DisclosureSEC source: 0001225208-21-002881 · doc4.xml · nonDerivative · entry 4 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionCommon Stock | 81 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002881 · doc4.xml · nonDerivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Reflects vesting and settlement of RSUs granted on February 15, 2018. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 58 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002880 · doc4.xml · derivative · entry 6 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F4 · shares: Reflects vesting and settlement of RSUs granted on February 15, 2018. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Tax withholdingCommon Stock | 24 | $136.21 | $3,269.04 |
DisclosureSEC source: 0001225208-21-002880 · doc4.xml · nonDerivative · entry 4 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionCommon Stock | 58 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002880 · doc4.xml · nonDerivative · entry 3 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Reflects vesting and settlement of RSUs granted on February 15, 2018. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 15, 2021 Filed Jun 2, 2021 20:46 UTC Amendment |
Herriott SimonPresident Health & Biosciences
|
Tax withholdingCommon Stock | 27 | $136.21 | $3,677.67 |
DisclosureSEC source: 0001225208-21-008817 · doc4a.xml · nonDerivative · entry 2 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 952 F1 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Number of shares withheld was misreported due to administrative error. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC |
Herriott SimonPresident Health & Biosciences
|
Exercise / conversionRestricted Stock Units · Derivative | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002882 · doc4.xml · derivative · entry 5 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,122 Underlying: Common Stock · 525 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F5 · derivative.exercise_date: The RSUs vested on February 14, 2021. F5 · derivative.expiration_date: The RSUs vested on February 14, 2021. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC |
Herriott SimonPresident Health & Biosciences
|
Tax withholdingCommon Stock | 173 | $136.21 | $23,564.33 |
DisclosureSEC source: 0001225208-21-002882 · doc4.xml · nonDerivative · entry 2 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC |
Herriott SimonPresident Health & Biosciences
|
Exercise / conversionCommon Stock | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002882 · doc4.xml · nonDerivative · entry 1 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionRestricted Stock Units · Derivative | 365 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002881 · doc4.xml · derivative · entry 5 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,356 Underlying: Common Stock · 365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F5 · derivative.exercise_date: The RSUs vested on February 14, 2021. F5 · derivative.expiration_date: The RSUs vested on February 14, 2021. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Tax withholdingCommon Stock | 120 | $136.21 | $16,345.20 |
DisclosureSEC source: 0001225208-21-002881 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionCommon Stock | 365 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002881 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 365 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002880 · doc4.xml · derivative · entry 5 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,469 Underlying: Common Stock · 365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F5 · derivative.exercise_date: The RSUs vested on February 14, 2021. F5 · derivative.expiration_date: The RSUs vested on February 14, 2021. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Tax withholdingCommon Stock | 146 | $136.21 | $19,886.66 |
DisclosureSEC source: 0001225208-21-002880 · doc4.xml · nonDerivative · entry 2 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.